Traci Bratton

Traci Bratton

| This email address is being protected from spambots. You need JavaScript enabled to view it.
Contact:
(205) 934-2040
traci@uab.edu 
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in older people in the United States. AMD affects 14 million U.S. adults, and this number will increase as the "baby boomer" generation ages.
“This recognition is important because it shows we’re doing the right things to make their time as employees rewarding, and we will continue to work earnestly with our faculty and staff to enhance their experience." said UAB President Ray Watts.
Through summer writing camps, writing contests, and initiatives with classroom teachers, the Red Mountain Writing Project is inspiring the next generation of writers.
A study by Courtney Peterson, assistant professor of nutrition sciences at the University of Alabama at Birmingham, showed that people who finished eating by early afternoon burned more fat and had fewer bouts of hunger.
Tests of cells collected from the umbilical cord blood vessel walls at birth can predict death or poor pulmonary outcomes in extremely preterm infants, say researchers at the University of Alabama at Birmingham.
Dr. Edward E. Partridge, who has served as the director of the University of Alabama at Birmingham Comprehensive Cancer Center since 2007, will be retiring from the position at the end of July. UAB is conducting a national search to find his successor.
Every day, students will work closely with nationally acclaimed novelists, essayists, and poets, all of whom have extensive teaching experience.
He appeared at ASC’s first gala fundraiser in 1999, returned in 2007, and was again was in the spotlight Sunday for the 2017 Viva Health Starlight Gala.
"This circadian fluctuation is now known as a risk factor for the progression of glaucoma. What we need to now answer is 'why is this circadian fluctuation happening?' Once we understand why circadian rhythm is a risk factor, we can begin to develop targeted treatments."
The partnership with Strata Oncology will provide patients with advanced or rare cancers with tumor profiling or sequencing at no cost aside from their typical co-pays. Average tumor profiling ordinarily costs $4,000 per test.
Page 1 of 153
Back to Top